Hook & thesis
FactSet Research Systems (FDS) has seen its share price derate sharply from the frothier levels of 2024-2025, hitting a 52-week low of $185 on 02/17/2026 and settling near $250 today. That decline has left the business trading at pragmatic multiples given its profitability and cash generation: market cap roughly $9.12 billion, free cash flow of $682.9 million, EV/EBITDA ~10.9x and a price-to-earnings ratio near 15.2x. We argue that these fundamentals plus imminent product-level catalysts support a trade that offers more than 30% upside from current levels.
The short version: buy FDS at current levels ($250.37) with a target of $325.50 and a stop at $221.00. The thesis rests on three pillars: resilient subscription-driven revenue, strong free cash flow and returns on capital, and early monetization of AI-enabled analytics (Portfolio Analytics MCP) that preserves FactSet's data moat rather than disintermediating it.
What FactSet does and why the market should care
FactSet is a global financial data and analytics platform serving the front, middle and back offices of buy-side and sell-side institutions, wealth managers, and corporate clients. Its revenue model is subscription-heavy, coming from workstations, enterprise data feeds, analytics and research management. That recurring structure makes FactSet a cash-generative business where relatively modest top-line growth can translate into high incremental free cash flow.
Why care now? The market punished information vendors in 2025-26 on fears that commodity AI chatbots could replace premium data and analytics. However, FactSet's product strategy — integrating governed, auditable analytics into workflows — aligns it with the way institutions will consume AI: curated, auditable, and embedded. The limited release of Portfolio Analytics MCP on 06/26/2026 brings governed performance, attribution and risk into conversational workflows, which should both protect and expand FactSet's addressable revenue in enterprise deployments.
Back the argument with the numbers
- Market cap: approximately $9.12 billion.
- Current price: $250.37 (previous close $245.55; intraday high $253.24).
- Valuation multiples: P/E ~15.2x, P/S ~3.73, EV/EBITDA ~10.92, EV/Sales ~4.18.
- Profitability and cash flow: EPS ~$16.13, free cash flow ~$682.9M, ROE ~27.6%, ROA ~13.9%.
- Leverage and balance sheet: debt-to-equity ~0.64, current ratio ~1.43, healthy liquidity profile.
- Share liquidity: average daily volume in the 30–90 day range ~1.05–1.2M; float ~36.3M shares.
Those numbers tell a consistent story: profitable, recurring revenues converting into solid free cash flow at reasonable multiples. With FCF nearing $700M, the market is effectively pricing FactSet at just over 13x free cash flow on a market-cap basis (market cap $9.12B / FCF $683M ≈ 13.3x). For a business with high retention and modest capex, that is not aggressive.
Valuation framing
FactSet's P/E near 15x and EV/EBITDA near 11x sit below growth-software-like multiples and above commodity data providers; they reflect an in-between market view. The stock's 52-week high of $453.41 (07/14/2025) shows how sentiment can overshoot on optimism; the 52-week low of $185 (02/17/2026) indicates the other extreme. At $250, you get the company at roughly half its recent peak market cap while it still produces ~27.6% ROE and strong cash flow. If management can stabilize subscription growth and show incremental revenue from AI-embedded products, multiple expansion to mid-to-high teens on P/E (or 14–16x EV/EBITDA) is reasonable — enough to support the >30% upside we target.
Catalysts (what can re-rate the stock)
- Q3 fiscal 2026 earnings (07/01/2026) - a clean beat on subscriptions or a raised guide would directly validate stabilization of the top line and drive multiple expansion.
- Product monetization: Portfolio Analytics MCP (06/26/2026 limited release) - early adoption and examples of revenue-linked deployments into buy-side workflows could shift the narrative from “AI threat” to “AI advantage.”
- Partnerships and ecosystem wins - extensions with data partners (example: continued partnerships with industry providers) can accelerate enterprise penetration and reduce client churn.
- Shareholder-friendly actions - steadied cash flow could prompt larger buybacks or dividend increases over time, supporting per-share metrics.
Trade plan
Actionable plan: go long FDS at an entry of $250.37. Target one: $325.50. Stop loss: $221.00. This trade is structured with a long-term time horizon - long term (180 trading days) - to allow for product adoption cycles and for the market to re-assess earnings momentum after the upcoming earnings release.
Why 180 trading days? Product rollouts into enterprise workflows and contractual renewals move slowly; a longer window accommodates subscription cadence, client case studies for Portfolio Analytics MCP, and potential re-rating from earnings beats. If you prefer a shorter timeline, a mid-term horizon of 45 trading days would be an alternative to trade around the 07/01/2026 earnings print, but expect higher volatility. For traders looking to scalp near-term momentum, a short term of 10 trading days could capture post-earnings pop or fade, but the risk-reward is compressed and noise-heavy.
Position sizing and risk framing
Use the $221 stop to limit downside to roughly 11.6% from entry. With the $325.50 target you capture ~30% upside. That is a favorable asymmetric setup (roughly 2.6:1 reward-to-risk). Keep position sizing consistent with your risk tolerance: if this is a core swing position, cap allocation so that a stop-out is within your acceptable loss budget (e.g., 1-2% of portfolio value).
Risks and counterarguments
- AI disruption is real and accelerating - The counterargument is that large language models and commoditized data feeds could compress pricing across the industry, shrinking FactSet's TAM and forcing margin compression. If customers substitute expensive terminals and bespoke data for lower-cost AI-driven workflows, revenue growth could deteriorate further.
- Macro and interest rate risk - A less favorable rate environment or recession could pressure buy-side budgets, slowing renewals and causing churn across subscription contracts.
- Execution on Product Monetization - Portfolio Analytics MCP needs to move from limited release to paid deployments. Execution delays, slow commercial traction, or weak ARR conversion would delay the re-rating thesis.
- Sentiment and technical levels - High short activity and volatile technicals can amplify downside. Recent short volumes have been significant on several trading days, which could accelerate moves lower in a risk-off environment.
- Counterpoint to our thesis - Even if FactSet executes on product integration, the market may still prefer faster-growing pure-play data/AI vendors and keep FactSet at muted multiples. In that scenario, earnings growth could be positive but still fail to lift the multiple materially.
How we'll be proved wrong
This trade will be invalidated if one or more of the following occurs: management reports materially weaker subscription retention or negative organic revenue growth; Portfolio Analytics MCP shows no paying customers or materially delayed commercialization; or macro-driven wholesale cuts to buy-side technology budgets that produce guidance downgrades. A decisive weekly close below $210 with rising volume and worsening fundamentals would also change the view.
Conclusion
FactSet today looks like a differentiated, cash-generative recurring-revenue business being priced as if secular threats are already realized. The balance sheet, profitability metrics (ROE ~27.6%), and free cash flow (~$683M) provide a safety buffer, while new product deployment and an upcoming earnings print create clear catalysts. The proposed trade - enter at $250.37, target $325.50, stop $221.00 over a long-term horizon of 180 trading days - balances upside potential with disciplined risk control. If the company validates product-led revenue growth and stabilizes subscription trends, a >30% upside and multiple expansion are credible outcomes. If not, the stop is in place to limit downside and reassess the thesis.
Trade summary: Buy FDS at $250.37, target $325.50, stop $221.00, long term (180 trading days), risk level: medium.